Dharmaj Crop Guard Ltd
Incorporated in 2015, Dharmaj Crop Guard manufactures and deals in pesticides including concessionaires of public health products for pest control, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]
- Market Cap ₹ 1,241 Cr.
- Current Price ₹ 367
- High / Low ₹ 391 / 165
- Stock P/E 23.7
- Book Value ₹ 117
- Dividend Yield 0.00 %
- ROCE 12.0 %
- ROE 9.24 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 3.15 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.6% over last 3 years.
- Debtor days have increased from 70.7 to 95.3 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|
136 | 193 | 298 | 388 | 524 | 654 | 951 | 1,063 | |
126 | 175 | 267 | 344 | 483 | 591 | 876 | 965 | |
Operating Profit | 10 | 18 | 31 | 44 | 41 | 63 | 75 | 99 |
OPM % | 8% | 9% | 10% | 11% | 8% | 10% | 8% | 9% |
1 | 1 | 1 | 2 | 4 | 3 | 2 | 3 | |
Interest | 2 | 2 | 1 | 3 | 2 | 3 | 13 | 13 |
Depreciation | 2 | 2 | 3 | 5 | 5 | 5 | 18 | 18 |
Profit before tax | 7 | 14 | 28 | 39 | 38 | 57 | 46 | 69 |
Tax % | 28% | 26% | 26% | 26% | 30% | 23% | 24% | |
5 | 11 | 21 | 29 | 27 | 44 | 35 | 52 | |
EPS in Rs | 25.10 | 6.54 | 12.74 | 11.62 | 7.95 | 13.13 | 10.31 | 15.49 |
Dividend Payout % | 0% | 0% | 0% | 1% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 38% |
3 Years: | 35% |
TTM: | 42% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | 7% |
TTM: | 23% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 12% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 2 | 16 | 16 | 25 | 34 | 34 | 34 |
Reserves | 9 | 19 | 40 | 60 | 281 | 326 | 361 |
20 | 20 | 27 | 37 | 52 | 112 | 116 | |
17 | 37 | 46 | 98 | 65 | 92 | 223 | |
Total Liabilities | 48 | 93 | 129 | 220 | 432 | 563 | 733 |
12 | 22 | 39 | 40 | 40 | 312 | 315 | |
CWIP | 0 | 2 | 1 | 18 | 90 | 2 | 3 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | 68 | 89 | 161 | 302 | 249 | 416 | |
Total Assets | 48 | 93 | 129 | 220 | 432 | 563 | 733 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
3 | 2 | 13 | 16 | -24 | 7 | 39 | |
-4 | -15 | -18 | -24 | -191 | -62 | -33 | |
0 | 12 | 6 | 7 | 214 | 57 | -9 | |
Net Cash Flow | -0 | -1 | 1 | 0 | -1 | 3 | -3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 46 | 63 | 44 | 81 | 51 | 66 | 95 |
Inventory Days | 52 | 67 | 68 | 74 | 62 | 66 | 68 |
Days Payable | 44 | 80 | 61 | 108 | 31 | 47 | 96 |
Cash Conversion Cycle | 54 | 49 | 51 | 47 | 81 | 84 | 67 |
Working Capital Days | 36 | 20 | 33 | 43 | 56 | 65 | 53 |
ROCE % | 39% | 42% | 40% | 17% | 15% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Aug - Newspaper Advertisement stating member to update the Email for the Upcoming 11th Annual General Meeting going to be held through Video Conferencing.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19 Aug - Management to meet Kanav Capital and Mittal Analytics virtually on Aug 22, 2025; no UPSI to be shared.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Aug
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13 Aug - Q1FY26 revenue ₹3,674Mn (+44%), EBITDA ₹507Mn (+88%), PAT ₹326Mn (+116%) with strong segment growth.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Aug - Investor Presentation for the Quarter ended June 30,2025.
Concalls
-
Aug 2025TranscriptNotesPPT
-
Jun 2025Transcript PPT REC
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT REC
-
Apr 2024TranscriptNotesPPTREC
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT REC
-
Jul 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
Business Overview:[1][2]
Company is in the business of agrochemical formulations & active ingredients and have the following business segments
a) Branded Formulations (B2C)
b) Institutional Formulations (B2B)
c) Active Ingredients (B2B)
Company manufactures pesticides, weedicides, fungicides, herbicides and has an active portfolio of 190+ products, catering
to a wide customer base including bulk consumers, retailers and export customers